ライフサイエンスコーパス: vascular cell adhesion molecule

1 ded by SAV, as measured by the expression of vascular cell adhesion molecule.

2 2.84-4.95] vs. 1.66 [1.22-2.63] p < 0.0001), vascular cell adhesion molecule 1 (539 [451-621] vs. 402

3 ntercellular adhesion molecule 2 (CD102) and vascular cell adhesion molecule 1 (CD106).

4 ated with the endothelial activation markers vascular cell adhesion molecule 1 (P < .001 for both) an

5 r adhesion molecule 1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1) were measure

6 shear stress to alpha4beta1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronect

7 In mice lacking endothelial vascular cell adhesion molecule 1 (VCAM-1) and in wild-t

8 elial dysfunctional markers, such as soluble vascular cell adhesion molecule 1 (VCAM-1) and intercell

9 Antibody neutralization of vascular cell adhesion molecule 1 (VCAM-1) and its ligan

10 The levels of soluble vascular cell adhesion molecule 1 (VCAM-1) and osteoprot

11 tudies revealed that the interaction between vascular cell adhesion molecule 1 (VCAM-1) and very late

12 Vascular cell adhesion molecule 1 (VCAM-1) expression, h

13 Although expression of vascular cell adhesion molecule 1 (VCAM-1) in endothelia

14 tercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in the lungs

15 but interaction with the endothelial ligand vascular cell adhesion molecule 1 (VCAM-1) may also play

16 neutrophils adhering to surfaces expressing vascular cell adhesion molecule 1 (VCAM-1) motivated the

17 Vascular cell adhesion molecule 1 (VCAM-1) plays a major

18 strate that the adhesion pathway mediated by vascular cell adhesion molecule 1 (VCAM-1) plays a role

19 s is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated o

20 uman umbilical vein endothelial cell (HUVEC) vascular cell adhesion molecule 1 (VCAM-1) upregulation.

21 Levels of vascular cell adhesion molecule 1 (VCAM-1) were measured

22 Here, we show that red pulp vascular cell adhesion molecule 1 (VCAM-1)(+) macrophage

23 d serves as an adhesive ligand that captures vascular cell adhesion molecule 1 (VCAM-1)(+) metastatic

24 -activated antibody (pro-antibody) targeting vascular cell adhesion molecule 1 (VCAM-1), a marker of

25 e chemotactic protein 1 (MCP-1), IL-6, IL-8, vascular cell adhesion molecule 1 (VCAM-1), and E-select

26 intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-select

27 essential for TNF-alpha-induced E-selectin, vascular cell adhesion molecule 1 (VCAM-1), and intercel

28 FimA, while RANTES, gamma interferon, IL-17, vascular cell adhesion molecule 1 (VCAM-1), and vascular

29 d factor, intracellular adhesion molecule 1, vascular cell adhesion molecule 1 (VCAM-1), E-selectin,

30 aluate expression of an inflammatory marker, vascular cell adhesion molecule 1 (VCAM-1), in atheroscl

31 ment and adherence to endothelium, including vascular cell adhesion molecule 1 (VCAM-1), intercellula

32 endothelial cells to synthesize E-selectin, vascular cell adhesion molecule 1 (VCAM-1), interleukin

33 ed significantly increased urinary levels of vascular cell adhesion molecule 1 (VCAM-1), P-selectin,

34 intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet-end

35 ody fragment directed against mouse or human vascular cell adhesion molecule 1 (VCAM-1), recently has

36 acrophage chemoattractant protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1), secretory ph

37 al variables, including the level of soluble vascular cell adhesion molecule 1 (VCAM-1), were assesse

38 cells to express adhesion molecules such as vascular cell adhesion molecule 1 (VCAM-1), which mediat

39 effect was specific for L-selectin, because vascular cell adhesion molecule 1 (VCAM-1)-mediated adhe

40 d intercellular adhesion molecule 1 (ICAM-1)/vascular cell adhesion molecule 1 (VCAM-1)-mediated adhe

41 uantitative behavioral outcomes, and a novel vascular cell adhesion molecule 1 (VCAM-1)-targeted magn

42 yte adhesion molecules (ELAM) E-selectin and vascular cell adhesion molecule 1 (VCAM-1).

43 of a4 integrins on the MCp with endothelial vascular cell adhesion molecule 1 (VCAM-1).

44 tercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1).

45 adhesion of eosinophils to various forms of vascular cell adhesion molecule 1 (VCAM-1, CD106), an in

46 Vascular cell adhesion molecule 1 (VCAM-1; CD106), a mem

47 of intercellular adhesion molecule 1 (ICAM1)/vascular cell adhesion molecule 1 (VCAM1), whose express

48 eduction of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1).

49 key cytokines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracell

50 issue inhibitor of metalloproteinases 1; and vascular cell adhesion molecule 1 [VCAM-1]) were measure

51 , vascular endothelial growth factor [VEGF], vascular cell adhesion molecule 1 [VCAM1], and GTP bindi

52 and alphaLbeta2 to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhe

53 es with their endothelial counter-receptors, vascular cell adhesion molecule 1 and intercellular adhe

54 ws for adhesion to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhe

55 Here, we identify vascular cell adhesion molecule 1 as the relevant recept

56 ing in the posttranscriptional regulation of vascular cell adhesion molecule 1 expression and a reduc

57 othelial tumor necrosis factor-alpha-induced vascular cell adhesion molecule 1 expression and monocyt

58 s correlated with a marked reduction in lung vascular cell adhesion molecule 1 expression and product

59 RK5 transcriptional activity and upregulated vascular cell adhesion molecule 1 expression.

60 ing three distinct subsets based on Flt3 and vascular cell adhesion molecule 1 expression.

61 ion of intracellular adhesion molecule 1 and vascular cell adhesion molecule 1 in cells and in kidney

62 ilonRII) cells; IL-4; IL-5; eosinophils, and vascular cell adhesion molecule 1 in the large airways a

63 on of monocyte chemoattractant protein-1 and vascular cell adhesion molecule 1 in wire-injured caroti

64 s/chemokines, leukotriene B(4) (LTB(4)), and vascular cell adhesion molecule 1 levels in the lungs, w

65 naling in the stromal cells and with reduced vascular cell adhesion molecule 1 production by them.

66 ivo with the Ad-Nnat increased expression of vascular cell adhesion molecule 1 protein.

67 We suggest that lymphocyte binding to vascular cell adhesion molecule 1 triggers a signaling p

68 ing of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 under the migrating le

69 ntercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 were reduced after whe

70 ased low-density lipoprotein uptake, VCAM-1 (vascular cell adhesion molecule 1) expression, apoptosis

71 esion (intracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in mye

72 ctin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1) was slightly up- or d

73 idase [MPO], matrix metalloproteinase 9, and vascular cell adhesion molecule 1) would be increased an

74 se 2, intracellular adhesion molecule 1, and vascular cell adhesion molecule 1), increased expression

75 ffect binding of VLA-4 to its ligand VCAM-1 (vascular cell adhesion molecule 1).

76 Vascular cell adhesion molecule 1, an adhesion molecule

77 le p75 tumor necrosis factor alpha receptor, vascular cell adhesion molecule 1, and matrix metallopro

78 selectin, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and tissue factor mes

79 We measured levels of hsCRP, ICAM-1, vascular cell adhesion molecule 1, and tumor necrosis fa

80 e intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1, C-peptide, insulin, a

81 sposed intercellular adhesion molecule 1 and vascular cell adhesion molecule 1, disruption or looseni

82 les (intercellular cell adhesion molecule 1, vascular cell adhesion molecule 1, E-selectin, and plate

83 scular endothelial growth factor receptor-2, vascular cell adhesion molecule 1, intercellular adhesio

84 in, von Willebrand factor (VWF), E-selectin, vascular cell adhesion molecule 1, intercellular adhesio

85 NF-kappaB activation also induced vascular cell adhesion molecule 1, keratinocyte chemoatt

86 both diminished inflammation (expression of vascular cell adhesion molecule 1, plaque macrophage con

87 cells adhering to culture plates coated with vascular cell adhesion molecule 1, SDF-1 and stem cell f

88 lular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1, soluble E-selectin, a

89 let), E-selectin (selectin endothelium), and vascular cell adhesion molecule 1, were also upregulated

90 In addition, NanS also modified vascular cell adhesion molecule 1, which orchestrates th

91 1, interleukin 1beta, interferon gamma, and vascular cell adhesion molecule 1.

92 ctin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.

93 f endothelial activation, angiopoietin 2 and vascular cell adhesion molecule 1.

94 nd intercellular adhesion molecule 1 but not vascular cell adhesion molecule 1.

95 in very late antigen 4 binding to its ligand vascular cell adhesion molecule 1.

96 d prevented monocyte adhesion by attenuating vascular cell adhesion molecule -1 and monocyte chemoatt

97 ctant protein-1 (-13% versus +0.2%), soluble vascular cell adhesion molecule-1 (-6% versus +1%), high

98 nce of early AMD was associated with soluble vascular cell adhesion molecule-1 (odds ratio per SD on

99 ecules intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (P < .05).

100 ellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 (P < 0.05 above bacter

101 ith elevated levels of NT-proBNP and soluble vascular cell adhesion molecule-1 (P< .001).

102 Soluble vascular cell adhesion molecule-1 (sVCAM-1) is a marker

103 rix metalloproteinase 9 (MMP-9), and soluble vascular cell adhesion molecule-1 (sVCAM-1) were dramati

104 ercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) were higher

105 intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin

106 In vivo molecular imaging of vascular cell adhesion molecule-1 (VCAM 1) P-selectin, a

107 lated up-regulation of the adhesion proteins vascular cell adhesion molecule-1 (VCAM) and intercellul

108 /mL, Group II: 0.14 (0.20) mug/mL, P = .02); vascular cell adhesion molecule-1 (VCAM-1) (Group I: 0.3

109 Binding of leukocytes to vascular cell adhesion molecule-1 (VCAM-1) activates sig

110 d by inhibition of TNF-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and could be

111 ercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) and diabetes

112 levels than PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endotheli

113 n inhibitory factor (rhMIF) in up-regulating vascular cell adhesion molecule-1 (VCAM-1) and intercell

114 Endothelial vascular cell adhesion molecule-1 (VCAM-1) and its ligan

115 177 as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and monocyte

116 ry signaling that controls expression of the vascular cell adhesion molecule-1 (VCAM-1) and monocyte

117 uction of the endothelial activation markers vascular cell adhesion molecule-1 (VCAM-1) and vascular

118 was abolished by CD29 blockade on hMSCs and vascular cell adhesion molecule-1 (VCAM-1) blockade on H

119 tercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by

120 tion, EGF treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in

121 Vascular cell adhesion molecule-1 (VCAM-1) expression wa

122 cells was p38 MAPK-dependent while increased vascular cell adhesion molecule-1 (VCAM-1) expression wa

123 We hypothesized that molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) expression wi

124 brain inflammation was used to induce global vascular cell adhesion molecule-1 (VCAM-1) expression.

125 iency also transiently augmented LPS-induced vascular cell adhesion molecule-1 (VCAM-1) expression.

126 e derivatives as novel, potent inhibitors of vascular cell adhesion molecule-1 (VCAM-1) expression.

127 y Wu et al presents additional evidence that vascular cell adhesion molecule-1 (VCAM-1) imaging in at

128 wnstream target genes tissue factor (TF) and vascular cell adhesion molecule-1 (VCAM-1) in diabetic a

129 ur angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary cu

130 Vascular cell adhesion molecule-1 (VCAM-1) is a cell sur

131 Vascular cell adhesion molecule-1 (VCAM-1) is expressed

132 croarray analysis of P0 and P3 revealed that vascular cell adhesion molecule-1 (VCAM-1) is up-regulat

133 vasive imaging of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) may identify

134 Vascular cell adhesion molecule-1 (VCAM-1) plays importa

135 ApoCIII increased EC expression of vascular cell adhesion molecule-1 (VCAM-1) protein and i

136 cess on CXC chemokine receptor 2 (CXCR2) and vascular cell adhesion molecule-1 (VCAM-1) using null st

137 effect of t-RA exposure on cell adhesion to vascular cell adhesion molecule-1 (VCAM-1), a well-estab

138 intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-select

139 cellular adhesion molecule-1 (MAdCAM-1) and vascular cell adhesion molecule-1 (VCAM-1), endothelial

140 ctivator 2, decay accelerating factor (DAF), vascular cell adhesion molecule-1 (VCAM-1), manganese su

141 acrophage chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), nuclear fact

142 lium and subsequent induction of endothelial vascular cell adhesion molecule-1 (VCAM-1), which is req

143 with very late antigen-4 (VLA-4) binding to vascular cell adhesion molecule-1 (VCAM-1), which is upr

144 ssing the endothelial cell adhesion molecule vascular cell adhesion molecule-1 (VCAM-1), which normal

145 ly as a consequence of reduced expression of vascular cell adhesion molecule-1 (VCAM-1), which regula

146 ant protein-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1).

147 hase and underwent firm adhesion mediated by vascular cell adhesion molecule-1 (VCAM-1).

148 on oxide that enables imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1).

149 nflammatory activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1).

150 tracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

151 tracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

152 binds to its main ligands, fibronectin, and vascular cell adhesion molecule-1 (VCAM-1).

153 tercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

154 ic kidney, which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late

155 Vascular cell adhesion molecule-1 (VCAM1) constitutes a

156 evels of the adhesion and signaling molecule vascular cell adhesion molecule-1 (VCAM1).

157 Although vascular cell adhesion molecule-1 (VLA-4 receptor) was e

158 CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-inde

159 oinflammatory proteins, cyclooxygenase-2 and vascular cell adhesion molecule-1 also in an Src kinase

160 decreased firm arrest of mouse monocytes on vascular cell adhesion molecule-1 and E-selectin in a sh

161 rabbits decreased collar-induced endothelial vascular cell adhesion molecule-1 and intercellular adhe

162 1 mRNA levels and inhibited cytokine-induced vascular cell adhesion molecule-1 and intercellular adhe

163 nockout mice showed significant decreases in vascular cell adhesion molecule-1 and intercellular adhe

164 In addition, CLP-increased vascular cell adhesion molecule-1 and intercellular adhe

165 le cells blocks Ang II-induced expression of vascular cell adhesion molecule-1 and intercellular adhe

166 tor T cells adhere to high concentrations of vascular cell adhesion molecule-1 and intercellular adhe

167 lished the blocking effect of kallistatin on vascular cell adhesion molecule-1 and monocyte chemoattr

168 pha-induced NF-kappaB activation, as well as vascular cell adhesion molecule-1 and monocyte chemoattr

169 repressor for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotact

170 nhanced the expression of adhesion molecules vascular cell adhesion molecule-1 and monocyte chemotact

171 Whereas vascular cell adhesion molecule-1 and P-selectin were no

172 erns of vascular adhesion molecules, such as vascular cell adhesion molecule-1 and platelet endotheli

173 ctin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 and secretion of the c

174 ntent), and endothelial dysfunction (soluble vascular cell adhesion molecule-1 and soluble intercellu

175 or inhibited adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin sp

176 nd demyelination by increasing expression of vascular cell adhesion molecule-1 and the transcytosis p

177 ement of tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 and tissue factor expr

178 n, and its interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular

179 82 augmented adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibrone

180 ontin by 12% (95% CI, -14% to -10%), soluble vascular cell adhesion molecule-1 by 14% (95% CI, -18% t

181 ion of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of hu

182 atory biomarkers, and carotid P-selectin and vascular cell adhesion molecule-1 expression by contrast

183 Furthermore, vascular cell adhesion molecule-1 expression in both mou

184 osis factor alpha (TNF alpha) stimulation of vascular cell adhesion molecule-1 expression in endothel

185 romoted superoxide production, and increased vascular cell adhesion molecule-1 expression in human ao

186 L-4F reduced vascular cell adhesion molecule-1 expression induced by

187 ung injury, CPAP-30 and STEP-30/30 increased vascular cell adhesion molecule-1 expression, but the ty

188 ased endothelial ROS production, endothelial vascular cell adhesion molecule-1 expression, matrix met

189 eukocytes was associated with an increase in vascular cell adhesion molecule-1 expression, which itse

190 rs treated with beta-blocker showed enhanced vascular cell adhesion molecule-1 expression.

191 pendent increase in plasma levels of soluble vascular cell adhesion molecule-1 in sickle mice was not

192 elial cell adhesion molecules E-selectin and vascular cell adhesion molecule-1 in the microvasculatur

193 of endothelial nitric oxide, superoxide, and vascular cell adhesion molecule-1 in vitro improved sign

194 duction in vitro and increased expression of vascular cell adhesion molecule-1 in vivo.

195 The expression of vascular cell adhesion molecule-1 induced by IgG-APS or

196 only volume-controlled ventilation increased vascular cell adhesion molecule-1 messenger RNA expressi

197 y be effectively replaced by transduction of vascular cell adhesion molecule-1 or intercellular adhes

198 with chronic PTSD had a greater increase in vascular cell adhesion molecule-1 over time (B = 0.003,

199 binant intercellular adhesion molecule 1 and vascular cell adhesion molecule-1 rather than endothelia

200 ion of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 surface expression in

201 alpha receptor 2, interleukin-6, and soluble vascular cell adhesion molecule-1 to the 20-year cumulat

202 of the p65 subunit of NF-kappaB to increase vascular cell adhesion molecule-1 transcription.

203 mooth muscle cell actin, and upregulation of vascular cell adhesion molecule-1 was also suppressed in

204 , and monocyte chemoattractant protein-1 and vascular cell adhesion molecule-1 were reduced.

205 nd their receptors and inhibition of VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercell

206 and endothelial activation markers (soluble vascular cell adhesion molecule-1) decreased but remaine

207 ction (intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) in 524 middle-aged wo

208 olecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), inducible nitric oxi

209 olecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), tumor necrosis facto

210 Tumour necrosis factor alpha, vascular cell adhesion molecule-1, 8-isoprostane, leptin

211 tissues, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expres

212 molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin.

213 protein, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and leptin and decrea

214 or-alpha, intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemotac

215 plasma intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and VEDS probands had

216 croM, Gal-1 increased eosinophil adhesion to vascular cell adhesion molecule-1, caused redistribution

217 sposed intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, disruption or looseni

218 or-alpha, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial selectin,

219 le tumor necrosis factor receptor-1, soluble vascular cell adhesion molecule-1, granulocyte colony-st

220 pression (ie, ET-1, ET-A and ET-B receptors, vascular cell adhesion molecule-1, IL-6, and fractalkine

221 RvE1 or RvD1 inhibited the expressions of vascular cell adhesion molecule-1, IL-8, macrophage infl

222 leukin-6, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, inducible nitric oxid

223 ation; downregulated the local expression of vascular cell adhesion molecule-1, intercellular adhesio

224 tly inhibited thrombin-mediated induction of vascular cell adhesion molecule-1, intercellular adhesio

225 EC, increasing the expression of E-selectin, vascular cell adhesion molecule-1, intercellular adhesio

226 Plasminogen activator inhibitor 1, vascular cell adhesion molecule-1, intracellular adhesio

227 receptor 1, hypoxia-inducible factor-1alpha, vascular cell adhesion molecule-1, macrophage scavenger

228 red fluorescence signals with immunoreactive vascular cell adhesion molecule-1, macrophages, and cath

229 Circulating levels of immunoglobulin A, vascular cell adhesion molecule-1, myeloperoxidase, and

230 steopontin), and leukocyte adhesion (soluble vascular cell adhesion molecule-1, soluble intracellular

231 selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor

232 ecules intracellular adhesion molecule-1 and vascular cell adhesion molecule-1, which caused a fourfo

233 iency of monocytes sheared in whole blood on vascular cell adhesion molecule-1, while characterizing

234 ivo magnetic resonance imaging enhanced with vascular cell adhesion molecule-1-targeted nanoparticles

235 coclustering within focal adhesive sites on vascular cell adhesion molecule-1.

236 , IL-16, monocyte chemotactic protein-1, and vascular cell adhesion molecule-1.

237 tumor necrosis factor-mediated expression of vascular cell adhesion molecule-1.

238 mooth muscle cell actin and up-regulation of vascular cell adhesion molecule-1.

239 levels of IL-6, serum amyloid P, and soluble vascular cell adhesion molecule-1.

240 h a peptide mimicking monocyte engagement by vascular cell adhesion molecule-1.

241 natriuretic peptide (NT-proBNP) and soluble vascular cell adhesion molecule-1.

242 late antigen-4 (VLA-4), which interacts with vascular cell adhesion molecule-1.

243 f TRPC3 channels and also B cell adhesion to vascular cell adhesion molecule-1.

244 ha(4)beta(1) and blocks its interaction with vascular cell adhesion molecule-1.

245 1beta-induced expression of IL-6, MCP-1, and vascular cell adhesion molecule-1.

246 lpha4beta1 and loss of binding to its ligand vascular cell adhesion molecule-1.

247 F-kappaB-responsive genes, but expression of vascular cell-adhesion molecule-1 (Vcam1) was particular

248 yr142-phosphorylated beta-catenin stimulates vascular cell-adhesion molecule-1 expression to increase

249 r to activate, its high-affinity state binds vascular cell adhesion molecule and fibronectin 100- to

250 Increased vascular cell adhesion molecule and intercellular adhesi

251 crease in C-reactive protein, nitrotyrosine, vascular cell adhesion molecule and monocyte superoxide

252 CD11b-negative) vascular cells that express vascular cell adhesion molecule and variably alpha-smoot

253 necrotic cores, and proinflammatory VCAM-1 (vascular cell adhesion molecule) and MCP-1 (monocyte che

254 dothelial activation and circulating soluble vascular cell adhesion molecule), and a significant impr

255 eceptors, including nitric oxide synthase 2, vascular cell adhesion molecule, and intercellular cell

256 ble-intercellular adhesion molecule, soluble-vascular cell adhesion molecule, and soluble-E-selectin

257 levels of C-reactive protein, fibrinogen, or vascular cell adhesion molecule between the groups.

258 over, among control subjects, plasma soluble vascular cell adhesion molecule concentrations were sign

259 al pro-brain natriuretic peptide and soluble vascular cell adhesion molecule, has low predictive accu

260 monocyte chemoattractant protein-1, soluble vascular cell adhesion molecule, high-sensitivity C-reac

261 lls, TH2-related cytokines, eosinophils, and vascular cell adhesion molecule in the bronchopulmonary

262 with rigidity of the corresponding loops in vascular cell adhesion molecule, intercellular adhesion

263 which are regulated by NF-kappaB, including vascular cell adhesion molecule, intracellular adhesion

264 onitored by NF-kappaB activation and surface vascular cell adhesion molecule levels on aortic endothe

265 in (P = 0.001), E-selectin (P = 0.0005), and vascular cell adhesion molecule (P = 0.0468) with +4 por

266 erleukin-6, intercellular adhesion molecule, vascular cell adhesion molecule, P-selectin, and E-selec

267 opulation of melanoma cells that express the vascular cell adhesion molecule PECAM1, but not VEGFR-2,

268 tal kininogen; decreased total cathepsin-L1, vascular cell adhesion molecule, periostin, and neutroph

269 aquaporin-1(+) high endothelial venules and vascular cell adhesion molecule-positive vessels.

270 ellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1, and sE-select

271 lycerides and lacked the increase in soluble vascular cell adhesion molecules (sVCAM)-1 evident in th

272 adhesion molecule type 1 (sICAM-1), soluble vascular cell adhesion molecule type 1 (sVCAM-1), and th

273 integrin, VLA-4, which binds to endothelial vascular cell adhesion molecule (VCAM) -1.

274 intercellular adhesion molecule (ICAM) 1 and vascular cell adhesion molecule (VCAM) 1 and for proper

275 ddressin cell adhesion molecule (MAdCAM) and vascular cell adhesion molecule (VCAM) appear to play ro

276 Competition between Fab and the ligand vascular cell adhesion molecule (VCAM) for binding to ce

277 helial expression of the inflammatory marker vascular cell adhesion molecule (VCAM) in cells and anim

278 od pressure monitoring, serum interleukin-6, vascular cell adhesion molecule (VCAM), and asymmetric d

279 ndothelial cells increased the expression of vascular cell adhesion molecule (VCAM)-1 and intercellul

280 Expression of vascular cell adhesion molecule (VCAM)-1 by endothelial

281 oxide (NO)-dependent signaling, and reduced vascular cell adhesion molecule (VCAM)-1 expression and

282 intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 form nanocluste

283 acity as showed by the reduced expression of vascular cell adhesion molecule (VCAM)-1 in human cultur

284 Vascular cell adhesion molecule (VCAM)-1 was assessed at

285 X)-2, tumor necrosis factor (TNF)-alpha, and vascular cell adhesion molecule (VCAM)-1 was increased i

286 llular adhesion molecule (ICAM)-1, IL-8, and vascular cell adhesion molecule (VCAM)-1 were assessed b

287 of intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and activated

288 leukin (IL)-6, white blood cell count (WBC), vascular cell adhesion molecule (VCAM)-1, and intercellu

289 actor (TNF)-alpha, endothelin (ET)-1, Ang-1, vascular cell adhesion molecule (VCAM)-1, and vascular e

290 , types I and IV collagen, and vitronectin), vascular cell adhesion molecule (VCAM)-1, or activating

291 of intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, platelet-endot

292 this is blocked by anti-alpha4beta1 or anti-vascular cell adhesion molecule (VCAM)-1.

293 in; 3) tumor necrosis factor (TNF)-alpha; 4) vascular cell adhesion molecule (VCAM); 5) interleukin (

294 ms, we demonstrate that spatial variation in vascular cell adhesion molecule (VCAM-1) expression corr

295 ctivated neutrophils, alpha(5)-integrins, or vascular cell adhesion molecule (VCAM-1) were performed

296 p-regulated expression levels of E-selectin, vascular cell adhesion molecule (VCAM-1), and intercellu

297 1 represses the expression of E-selectin and vascular cell adhesion molecule (VCAM-1), two cytokine-i

298 cellular adhesion molecule (ICAM-1/CD54) and vascular cell adhesion molecule (VCAM/CD106); and the gr

299 (VEGF), soluble cell adhesion molecules (ie, vascular cell adhesion molecule [VCAM], intercellular ce

300 enhanced intercellular adhesion molecule and vascular cell adhesion molecule within the islets when s